Richard A. Schnizer

Array ( [id] => 11561902 [patent_doc_number] => 09624476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Conditionally replicating adenovirus' [patent_app_type] => utility [patent_app_number] => 15/183661 [patent_app_country] => US [patent_app_date] => 2016-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 19844 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15183661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16336717 [patent_doc_number] => 10787664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-29 [patent_title] => Compounds of chemically modified oligonucleotides and methods of use thereof [patent_app_type] => utility [patent_app_number] => 15/163816 [patent_app_country] => US [patent_app_date] => 2016-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 92 [patent_no_of_words] => 21923 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12166286 [patent_doc_number] => 09885049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-06 [patent_title] => 'Modulation of pre-MRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease' [patent_app_type] => utility [patent_app_number] => 15/160438 [patent_app_country] => US [patent_app_date] => 2016-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 33300 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15160438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11046288 [patent_doc_number] => 20160243246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'HYALURONIC ACID-NUCLEIC ACID CONJUGATE AND COMPOSITION FOR NUCLEIC ACID DELIVERY CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/151632 [patent_app_country] => US [patent_app_date] => 2016-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9115 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17408192 [patent_doc_number] => 11249071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-15 [patent_title] => Reactivation of x chromosome genes [patent_app_type] => utility [patent_app_number] => 15/138208 [patent_app_country] => US [patent_app_date] => 2016-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 90 [patent_no_of_words] => 25222 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15138208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11336934 [patent_doc_number] => 20160362689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-15 [patent_title] => 'DIFFERENTIALLY EXPRESSED MICRORNA MOLECULES FOR THE TREATMENT AND DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/132061 [patent_app_country] => US [patent_app_date] => 2016-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16833 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15132061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521876 [patent_doc_number] => 09605263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Compositions for modulating C9ORF72 expression' [patent_app_type] => utility [patent_app_number] => 15/130818 [patent_app_country] => US [patent_app_date] => 2016-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29554 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15130818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11457373 [patent_doc_number] => 20170051279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'VASCULAR RE-MODELLING' [patent_app_type] => utility [patent_app_number] => 15/099027 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 19538 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15099027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11018400 [patent_doc_number] => 20160215352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'Methods for Diagnosing Prostate Cancer Using MicroRNAs' [patent_app_type] => utility [patent_app_number] => 15/095382 [patent_app_country] => US [patent_app_date] => 2016-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31436 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15095382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11074294 [patent_doc_number] => 20160271258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Dual Peptide-Mediated Targeted Delivery System' [patent_app_type] => utility [patent_app_number] => 15/074698 [patent_app_country] => US [patent_app_date] => 2016-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16558 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15074698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11491538 [patent_doc_number] => 20170065724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'METAL-PARTICLE-BASED ORAL-ADMINISTRATING LIVER-SPECIFIC NUCLEIC ACID DELIVERY SYSTEM AND METHOD OF MANUFACTURING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/074443 [patent_app_country] => US [patent_app_date] => 2016-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6608 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15074443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12204834 [patent_doc_number] => 20180050060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'PREECLAMPSIA' [patent_app_type] => utility [patent_app_number] => 15/559815 [patent_app_country] => US [patent_app_date] => 2016-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22892 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059597 [patent_doc_number] => 20160256559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'STERICALLY STABILIZED CATIONIC NANOCARRIER, KITS AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 15/060663 [patent_app_country] => US [patent_app_date] => 2016-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16038 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15060663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11921633 [patent_doc_number] => 09789194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Graft copolymer polyelectrolyte complexes for drug delivery' [patent_app_type] => utility [patent_app_number] => 15/056386 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26821 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15056386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17527840 [patent_doc_number] => 11300519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-12 [patent_title] => Reagents and methods for detecting infectious diseases [patent_app_type] => utility [patent_app_number] => 15/552196 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 18549 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 294 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12217512 [patent_doc_number] => 20180055869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING RNA' [patent_app_type] => utility [patent_app_number] => 15/550112 [patent_app_country] => US [patent_app_date] => 2016-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30760 [patent_no_of_claims] => 170 [patent_no_of_ind_claims] => 101 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11852026 [patent_doc_number] => 20170226518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/019916 [patent_app_country] => US [patent_app_date] => 2016-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20276 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12808558 [patent_doc_number] => 20180161356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => TAU ANTISENSE OLIGOMERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/549021 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11040470 [patent_doc_number] => 20160237427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'Tau Antisense Oligomers and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/016169 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 234 [patent_figures_cnt] => 234 [patent_no_of_words] => 63008 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15016169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12151816 [patent_doc_number] => 20180023080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'Long Non-Coding RNA For The Treatment Of Endothelial Dysfunction' [patent_app_type] => utility [patent_app_number] => 15/548329 [patent_app_country] => US [patent_app_date] => 2016-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10713 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548329 [rel_patent_id] =>[rel_patent_doc_number] =>)